Hybio Pharmaceutical Co., Ltd. (300199.SZ) SHZ

22.70

+0.51(+2.30%)

Updated at June 02 03:07PM

Currency In CNY

Valuation

Market Cap16.37B
Enterprise Value17.92B
P/E Ratio219.27
PEG Ratio-0.12
Price/Sales Ratio20.98
Price/Book Ratio27.95
Enterprise/Revenue22.76
Enterprise/EBITDA92.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.16

Management Effectiveness

Return On Assets0.03
Return On Equity0.14

Income Statement

Revenue966.35M
Revenue/Share1.05
Gross Profit564M
EBITDA295.01M
Net Income36.57M
Diluted EPS0.04

Balance Sheet

Total Cash108.74M
Total Cash/Share0.12
Total Debt1.8B
Total Debt/Equity2.43
Current Ratio0.43
Book Value Per Share0.83

Price History

52-Week Change51.43
52-Week High31.19
52-Week Low14.06
Moving Average 50 Days21.39
Moving Average 200 Days20.55

Statistics

Average Volume50.05M
Shares Outstanding883.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio1.03
Last Split Factor2:1
Last Split DateApril 14, 2015